- Healthy Lifestyle Advice and Practice Among Cancer Survivors in the US
- Reassessing Treatment Outcomes Following Immune-Related Adverse Events—Reply
- Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
- Challenges in Interpreting MELATORCH Trial Outcomes—Reply
- Long-Term Outcomes in Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib
- Rethinking Treatment Intent Beyond the Curative-Palliative Binary in Modern Oncology
- Multiple Spinal Intradural Tumors and a Pigmented Skin Lesion
- Embracing Highly Effective Obesity Therapies to Improve Cancer Treatment and Survivorship
- Clarification for Gleason Pattern
- Quality of Care For Young Adult Patients With Cancer at the End of Life
- Reassessing Utility in the MyLungHealth Trial—Reply
- Reassessing Utility in the MyLungHealth Trial
- Local Salvage Therapy Alone for Local Recurrence of Prostate Cancer After Radiotherapy
- Young-Onset Colorectal Cancer by Education
- Clonal Hematopoiesis and Risk of Trastuzumab-Related Cardiotoxic Effects
